Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I Trial of 131I-HuCC49-deltaCH2 for Colon Cancer.

Trial Profile

Phase I Trial of 131I-HuCC49-deltaCH2 for Colon Cancer.

Phase of Trial: Phase I

Latest Information Update: 24 Jan 2013

At a glance

  • Drugs Monoclonal antibody CC49 I-131 (Primary)
  • Indications Colorectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Nov 2005 Status changed from recruiting to completed.
    • 29 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top